WHO Model List

haloperidol

International nonproprietary name (English: haloperidol). Brand names vary by country.

Indications retained by WHO

Palliative care; Schizophrenia or other primary psychotic disorders.

Listed forms and strengths

Oral > Liquid: 2 mg per mL
Oral > Solid: 0.5 mg; 2 mg; 5 mg
Parenteral > General injections > unspecified: 5 mg per mL in 1-mL ampoule
Parenteral > General injections > IM: 5 mg per mL in ampoule
Oral > Solid: 2 mg; 5 mg

Forms retained in the model list; presentations available in each country may differ.

General information from the WHO list. It replaces neither the prescription nor the leaflet: dosage and duration are for the doctor or pharmacist to decide.

Source: WHO electronic Essential Medicines List (2025 edition), checked on 14/11/2026. An error or an imprecision? Let us know